Abstract
Angiotensin I-converting enzyme (ACE) inhibition has revolutionised cardiovascular care, yet classical inhibitors face safety and efficacy challenges. Here, Professors Ravi Acharya and Edward Sturrock review the historical foundation of ACE inhibition, the present landscape of structural and therapeutic innovations, and the future clinical promise for cardiovascular diseases and beyond.
| Original language | English |
|---|---|
| Specialist publication | Hospital Healthcare Europe |
| Publisher | Cogora |
| Publication status | Published - 25 Sept 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'ACE inhibition: past, present and future'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS